Contact

For inquiries regarding the utilization of ethnobotanicals, or in case you are experiencing an adverse situation or difficulty integrating and experience, please read this page. For inquiries regarding legal support , please read this page.

  • We don’t offer sessions of ayahuasca or iboga.
  • We don’t recommend centers or people who perform/do sessions.

    map mapa marcador ICEERS

    Office

    Carrer de Sepúlveda, 65 , Oficina 2, 08015 Barcelona España +34 931 88 20 99
    placebo effect microdosing psychedelics ICEERS study efecto placebo microdosis psicodélicos

    Influence of the Placebo Effect in Microdosing Psychedelics

    15.12.2020

    Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: a systematic review

    Authors:
    Genís Oña, and José Carlos Bouso

    Journal:
    Neuroscience and Biobehavioral Reviews

    Year:
    2020

     

    About the study

    The increased interest by Western societies in microdosing with psychedelic drugs, especially LSD and psilocybin, lies primarily on its mood-enhancing effects, as well as an improved creative thinking and the relief of various psychological disorders.

    In order to summarize the current evidence on microdosing and help future studies, this study presents a systematic review exploring issues like the safety of microdosing, main reported benefits, and what aspects of these benefits might be attributed to a placebo effect.

    To conclude, the authors state the limitations of the available evidence and directions for future research. In terms of risks and benefits, several contradictory results were found, but they could be the result of the different study designs used.

     

    Abstract

    Rationale: Microdosing psychedelic drugs — that is, taking sub-behavioral doses of lysergic acid diethylamide (LSD) or psilocybin — is a growing practice in Western societies. Taken mainly for creative or mood-enhancing purposes, thousands of users are increasingly being exposed to (micro)doses of psychedelic drugs.

    Methods: In this systematic review, we searched the available evidence from human studies, focusing our results in terms of three main axes: efficacy, safety, and the influence of the placebo effect in microdosing practices. While the available evidence has some strengths (e.g. large sample sizes, robust methodologies) there are also remarkable limitations (e.g. gender bias, heterogeneity of dosing schedules and drugs used).

    Results: Highly contradictory results have been found, showing both the benefits and detriments of microdosing in terms of mood, creative processes, and energy, among other regards. This review provides a general overview of the methods and approaches used, which could be useful for improving future studies.

     

    Link to the article

     

    Contact ICEERS Research team

     
    Photo by Sonika Agarwal on Unsplash.

    Categories: Psychedelics , Studies & papers
    Tags: LSD , psilocybin , psychoactive , psychedelics , hallucinogens , microdosing , placebo , study